Probiotic (VSL#3) for Gulf War Illness

reportActive / Technical Report | Accesssion Number: AD1190492 | Open PDF

Abstract:

The overall objective of the study is to determine the effect of probiotic Visbiome(trademark) on: 1) Intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2) Non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS, the symptoms of Gulf War (GW) illness, 3) Serum pro- and anti-inflammatory cytokines, 4) fecal microbiota. The manuscript on The Effect of probiotics on IBS and GW illness was published in Oct, 2022. The effect of probiotics on serum cytokines was presented on Oct 25, 2022 in the Am Gastroenterology Conference. The stool samples analysis is ongoing.

Author(s):
Tuteja, Ashok
Author Organization(s):
WESTERN INST FOR BIOMEDICAL RESEARCH SALT LAKE CITY UT
Funding Organization(s):
ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND FORT DETRICK MD, FORT DETRICK , MD
Document Type:
Technical Report/Annual Report
Publication Date:
2022 Nov 01
Pagination:
9

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution Code:
A - Approved For Public Release
Distribution Statement: Public Release

RECORD

Collection: TRECMS
Identifying Numbers
Grant Number(s):
W81 XWH-10-1-0593
Subject Terms
Communities of Interest:
No COI(s) Identified
Descriptor(s):
biomedical research, persian gulf syndrome, colonic diseases, gut microbiome, microbiomes, pain, probiotics, cytokines, department of defense, diseases, information operations, risk factors, gastroenterology
Keyword(s):
ibs(irritable bowel syndrome), gwi(gulf war illness), visbiome
Subject Categories:
Biological and Medical Sciences
Creation Date:
2023 Jan 17
Update Date:
2023 Feb 08